|
Volumn 67, Issue 1, 2015, Pages 11-14
|
Efficacy of the β3-adrenoceptor agonist mirabegron for the treatment of overactive bladder by severity of incontinence at baseline: A post hoc analysis of pooled data from three randomised phase 3 trials
|
Author keywords
Correlation analysis; Efficacy; Incontinence; Mirabegron; Overactive bladder; Severity
|
Indexed keywords
MIRABEGRON;
PLACEBO;
ACETANILIDE DERIVATIVE;
BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT;
THIAZOLE DERIVATIVE;
ARTICLE;
CLINICAL ASSESSMENT;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG EFFICACY;
FULL ANALYSIS SET INCONTINENCE;
HUMAN;
INCONTINENCE;
MAJOR CLINICAL STUDY;
MICTURITION;
OVERACTIVE BLADDER;
POST HOC ANALYSIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
THERAPY EFFECT;
URINARY URGENCY;
AGED;
CLINICAL TRIAL;
COMPLICATION;
DOUBLE BLIND PROCEDURE;
FEMALE;
MALE;
MIDDLE AGED;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
SEVERITY OF ILLNESS INDEX;
URINARY BLADDER, OVERACTIVE;
URINARY INCONTINENCE;
ACETANILIDES;
ADRENERGIC BETA-3 RECEPTOR AGONISTS;
AGED;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
SEVERITY OF ILLNESS INDEX;
THIAZOLES;
URINARY BLADDER, OVERACTIVE;
URINARY INCONTINENCE;
URINATION;
|
EID: 84925127747
PISSN: 03022838
EISSN: 18737560
Source Type: Journal
DOI: 10.1016/j.eururo.2014.06.052 Document Type: Article |
Times cited : (44)
|
References (9)
|